A randomized controlled trial of levosimendan to reduce mortality in high risk cardiac surgery patients (CHEETAH): rationale and design
Zangrillo, A, Alvaro, G., MD, Pisano, A., MD, Guarracino, F., MD, Lobreglio, R., MD, Bradic, N., MD, Lembo, R., MSc, Gianni, S., MD, Calabrò, M.G., MD, Likhvantsev, V., PhD, Grigoryev, E., MD, Buscaglia, G., MD, Pala, G., MD, Auci, E., MD, Amantea, B., MD, Monaco, F., MD, De Vuono, G., MD, Corcione, A., MD, Galdieri, N., MD, Cariello, C., MD, Bove, T., MD, Fominskiy, E., MD, PhD, Auriemma, S., MD, Baiocchi, M., MD, Bianchi, A., MD, Frontini, M., MD, Paternoster, G., MD, Sangalli, F., MD, Wang, C.Y., MBChB, Zucchetti, M.C., MD, Biondi Zoccai, G., MD, MSc, Gemma, M., MD, Lipinski, M.J., MD, PhD, Lomivorotov, V.V., MD, PhD, Landoni, G
Published in The American heart journal (01.07.2016)
Published in The American heart journal (01.07.2016)
Get full text
Journal Article